Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06477302

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Construction and Psychometric Properties of the Therapeutic Adherence Scale for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC).

Status
Recruiting
Phase
Study type
Observational
Enrollment
281 (estimated)
Sponsor
Instituto Nacional de Cancerologia de Mexico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Detailed description

For the recruitment patients with lung cancer diagnosis that arrive at the Respiratory Rehabilitation service will be asked if they are willing to participate and fill out the STA. It will be explained to them as clearly as possible the objective, procedure, risks and benefits of the study and a copy of the Informed Consent will be provided. Lung cancer patients attending the Pulmonary Rehabilitation service will be approached and a verbal explanation of the study will be given.

Conditions

Interventions

TypeNameDescription
BEHAVIORALScale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)Patients will be given a measurement instrument to determine the level of therapeutic adherence.

Timeline

Start date
2023-06-23
Primary completion
2026-06-23
Completion
2027-06-23
First posted
2024-06-27
Last updated
2025-12-23

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06477302. Inclusion in this directory is not an endorsement.